Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: Comparison with normal bone marrow cells

British Journal of Haematology

Volumn 105, Issue 2, 1999, Pages 402-411

  Janowska Wieczorek, Anna ^a   Marquez, Leah A ^a   Matsuzaki, Akinobu ^a   Hashmi, Haroon R ^a   Larratt, Lori M ^a   Boshkov, Lynn M ^a   Turner, A Robert ^a   Zhang, Melissa C ^c   Edwards, Dylan R ^b   Kossakowska, Anna E ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c Edmonton Centre ^*

Author keywords

Acute myelogenous leukaemia; MMP 2; MMP 9; TIMP 1; TIMP 2

Indexed keywords

GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW CELL; CELL STRAIN HL 60; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; MONONUCLEAR CELL; NORTHERN BLOTTING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; ZYMOGRAPHY;

EID: 0032898121     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01352.x     Document Type: Article

References (55)

1. Alexander, C.M. & Werb, Z. (1992) Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vivo. Journal of Cell Biology, 118, 727-739.
2. Avalos, B.R., Kaufman, S.E., Tomonaga, M., Williams, R.E., Golde, D.W. & Gasson, J.C. (1988) K-562 cells produce and respond to human erythroid-potentiating activity. Blood, 71, 1720-1725.
3. Barille, S., Akhoundi, C., Collette, M., Mellerin, M.-P., Rapp, M.-J., Harousseau, J.-L., Bataille, R. & Amiot, M. (1997) Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood, 90, 1649-1655.
4. Basset, P., Okada, A., Chenard, M.-P., Kannan, R., Stoll, I., Anglard, P., Bellocq, J.-P. & Rio, M.-C. (1997) Matrix metalloproteinases as stromal effectors of human carcinoma progression: therapeutic implications. Matrix Biology, 15, 535-541.
5. Beranger, J.-Y., Godeau, G., Frances, C., Robert, L. & Hornebeck, W. (1994) Presence of gelatinase A and metalloelastase type protease at the plasma membrane of human skin fibroblasts: influence of cytokines and growth factors on cell-associated metallopeptidase levels. Cell Biology International, 18, 715-722.
6. Birkedal-Hansen, H., Moore, W.G.I., Bodden, M.K., Windsor, L.J., Birkedal-Hansen, B., DeCarlo, A. & Engler, J.A. (1993) Matrix metalloproteinases: a review. Critical Reviews in Oral Biology and Medicine, 4, 197-250.
7. Borregaard, N. & Cowland, J.B. (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood, 89, 3503-3521.
8. Chambers, A.F. & Matrisian, L.M. (1997) Changing views of the role of matrix metalloproteinases in metastasis. Journal of the National Cancer Institute, 89, 1260-1270.
9. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156-159.
10. Coulombel, L., Eaves, A.C. & Eaves, C.J. (1983) Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer. Blood, 62, 291-297.
11. DeClerck, Y.A., Perez, N., Shimada, H., Boone, T.C., Langley, K.E. & Taylor, S.M. (1992) Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Research, 52, 701-708.
12. Denhardt, D.T., Feng, B., Edwards, D.R., Cocuzzi, E.T. & Malyankar, U.M. (1993) Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacology and Therapeutics, 59, 329-341.
13. Doeherty, A.J.P., Lyons, A., Smith, B.J., Wright, E.M., Stephens, P.E., Harris, T.J.R., Murphy, G. & Reynolds, J.J. (1985) Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature, 318, 66-69.
14. Freireich, E.J. (1984) Acute leukemia: a prototype of disseminated cancer. Cancer, 53, 2026-2032.
15. Goetzl, E.J., Banda, M.J. & Leppert, D. (1996) Matrix metalloproteinases in immunity. Journal of Immunology, 156, 1-4.
16. Goldberg, G.I., Strongin, A., Collier, I.E., Genrich, L.T. & Marmer, B.L. (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. Journal of Biological Chemistry 267, 4583-4591.
17. Gomez, D.E., Alonso, D.F., Yoshiji, H. & Thorgeirsson, U.P. (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. European Journal of Cell Biology, 74, 111-122.
18. Guedez, L., Courtemanch, L. & Stetler-Stevenson, M. (1998) Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood, 92, 1342-1349.
19. Hayakawa, T., Yamashita, K., Ohuchi, E. & Shinagawa, A. (1994) Cell growth promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). Journal of Cell Science, 107, 2373-2379.
20. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E. & Iwata, K. (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: a possible new growth factor in serum. FEBS Letters, 298, 29-32.
21. Heussen, C. & Dowdle, E.B. (1980) Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry, 102, 196-202.
22. Howard, E.W. & Banda, M.J. (1991) Binding of tissue inhibitor of metalloproteinases-2 to two distinct sites on human 72-kDa gelatinase. Journal of Biological Chemistry, 266, 17972-17977.
23. Janiak, M., Hashmi, H.R. & Janowska-Wieczorek, A. (1994) Use of the Matrigel-based assay to measure the invasiveness of leukemic cells. Experimental Hematology, 22, 559-565.
24. Khokha, R. & Denhardt, D.T. (1989) Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion. Invasion Metastasis, 9, 391-405.
25. Kleiner, D.E. & Stetler-Stevenson, W.G. (1994) Quantitative zymography: detection of picogram quantities of gelatinases. Analytical Biochemistry, 218, 325-329.
26. Kossakowska, A.E., Hinek, A., Edwards, D.R., Lim, M.S., Zhang, C.-L., Breitman, D.R., Prusinkiewicz, C., Stabbler, A.L., Urbanski, L.S. & Urbanski, S.J. (1998) Proteolytic activity of human non-Hodgkin's lymphomas. American Journal of Pathology, 152, 565-576.
27. Kossakowska, A.E., Urbanski, S.J. & Edwards, D.R. (1991) Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas. Blood, 77, 2475-2481.
28. Kossakowska, A.E., Urbanski, S.J., Huchcroft, S.A. & Edwards, D.R. (1992) Relationship between the clinical aggressiveness of large immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. Oncology Research, 4, 233-240.
29. Kossakowska, A.E., Urbanski, S.J., Watson, A., Hayden, L.J. & Edwards, D.R. (1993) Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncology Research, 5, 19-28.
30. Llano, E., Pendas, A.M., Knauper, V., Sorsa, T., Salo, T., Salido, E., Murphy, G., Simmer, J.P., Bartlett, J.D. & Lopez-Otin, C. (1997) Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry, 36, 15101-15108.
31. MacDougall, J.R. & Matrisian, L.M. (1995) Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Reviews, 14, 351-362.
32. Massova, I., Khotra, L.P., Fridman, R. & Mabashery, S. (1998) Matrix metalloproteinases: structures, evolution, and diversification. FASEB Journal, 12, 1075-1095.
33. Matsuzaki, A. & Janowska-Wieczorek, A. (1997) Unstimulated human acute myelogenous leukemia blasts secrete matrix metalloproteinases. Journal of Cancer Research and Clinical Oncology, 123, 100-106.
34. Mayani, H., Guilbert, L.J., Clark, S.C., Belch, A.R. & Janowska-Wieczorek, A. (1992a) Composition and functional integrity of the in vitro hemopoietic microenvironment in acute myelogenous leukemia: effect of macrophage colony-stimulating factor. Experimental Hematology, 20, 1077-1084.
35. Mayani, H., Guilbert, L.J., Clark, S.C. & Janowska-Wieczorek, A. (1991) Inhibition of hematopoiesis in normal human long-term marrow cultures treated with recombinant human macrophage colony-stimulating factor. Blood, 78, 651-657.
36. Mayani, H., Guilbert, L.J. & Janowska-Wieczorek, A. (1992b) Biology of the hematopoietic microenvironment. European Journal of Haematology, 49, 225-233.
37. Moll, U.M., Youngleib, G.L., Rosinski, K.B. & Quigley, J.P. (1990) Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Research, 50, 6162-6170.
38. Murate, T., Yamashita, K., Isogai, C., Suzuki, H., Ichihara, M., Hatano, S., Nakahara, Y., Kinoshita, T., Nagasaka, T., Yoshida, S., Komatsu, N., Miura, Y., Hotta, T., Fujimoto, N., Saito, H. & Hayakawa, T. (1997) The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet-and megakaryocyte-derived TIMPs in bone marrow fibrosis. British Journal of Haematology, 99, 181-189.
39. Murphy, G. & Willenbrock, F. (1995) Tissue inhibitor of matrix metalloendopeptidases. Methods in Enzymology, 248, 496-510.
40. Nemeth, J.A., Rafe, A., Steiner, M., & Goolsby, C.L. (1996) TIMP-2 growth-stimulatory activity: a concentration-and cell type-specific response in the presence of insulin. Experimental Cell Research, 224, 110-115.
41. Oliver, G.W., Leferson, J.D., Stetler-Stevenson, W.G., & Kleiner, D.E. (1997) Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Analytical Biochemistry, 244, 161-166.
42. Ries, C., Kolb, H. & Petrides, P.E. (1994) Regulation of 92-kD gelatinase in HL-60 leukemia cells: tumor necrosis factor-α as an autocrine stimulus for basal-and phorbol ester-induced secretion. Blood, 83, 3638-3646.
43. Sambrook, J., Fritsch, E.M. & Maniatis, T. (1989) Extraction and purification of RNA. Molecular Cloning: a Laboratory Manual, 2nd edn. pp. 7.19-7.22. Cold Spring Harbor Laboratory Press, New York.
44. Sawicki, G., Matsuzaki, A. & Janowska-Wieczorek, A. (1998) Expression of the active form of MMP-2 on the surface of leukemic cells accounts for their in vitro invasion. Journal of Cancer Research and Clinical Oncology, 124, 245-252.
45. Schnaper, H.W., Grant, D.S., Stetler-Stevenson, W.G., Fridman, R., D'Orazi, G., Murphy, A.N., Byrd, R.E., Hoythya, M., Fuerst, T.R., French, D.L., Quigley, J.P. & Kleinmann, H.K. (1993) Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. Journal of Cell Physiology, 156, 235-246.
46. Schweitzer, C.M., van der Schoot, C.E., Drager, A.M., van der Valk, P., Zevenbergen, A., Hooibrink, B., Westra, A.H. & Langenhuijsen, M.M.A.C. (1995) Isolation and culture of human bone marrow endothelial cells. Experimental Hematology, 23, 41-48.
47. Stetler-Stevenson, W.G. (1994) Progelatinase A activation during tumor cell invasion. Invasion Metastasis, 14, 259-268.
48. Stetler-Stevenson, W.G., Bersch, N. & Golde, D.W. (1992) Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity. FEBS Letters, 296, 231-234.
49. Stetler-Stevenson, W.G., Hewitt, R. & Corcoran, M. (1996) Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Seminars in Cancer Biology, 7, 47-154.
50. Stetler-Stevenson, M., Mansoor, A., Lim, M., Fukushima, P., Kehrl, J., Marti, G., Ptaszynski, K., Wang, J. & Stetler-Stevenson, W.G. (1997) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in reactive and neoplastic lymphoid cells. Blood, 89, 1708-1715.
51. Urbanski, S.J., Edwards, D.R., Maitland, A., Leco, K.J., Watson, A. & Kossakowska, A.E. (1992) Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. British Journal of Cancer, 66, 1188-1194.
52. Verfaillie, C., Hurley, R., Bhatia, R. & McCarthy, J.B. (1994) Role of bone marrow matrix in normal and abnormal hematopoiesis. Critical Reviews in Oncology/Hematology, 16, 201-224.
53. Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T. & Okada, Y. (1993) Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. Journal of Cell Science, 104, 991-999.
54. Welgus, H.G., Senior, R.M., Parks, W.C., Kahn, A.J., Ley, T.J., Shapiro, S.D. & Campbell, E.J. (1992) Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation. Matrix Supplement, 1, 363-367.
55. Wong, H., Anderson, W.D., Cheng, T. & Riabowol, K.T. (1994) Monitoring mRNA expression by polymerase chain reaction: the 'primer-dropping' method. Analytical Biochemistry, 223, 251-258.